Neal Cutler, Chief Executive Officer of Worldwide Clinical Trials has been named by the 2017 European CEO Awards the Best CEO in the CRO Industry.
This honour recognises Cutler’s contributions as the founder and CEO of Worldwide, one of the world’s leading full-service contract research organisations (CROs).
The annual European CEO Awards highlight the achievements of CEOs across a variety of industries whose contributions are driving their companies forward.
Background
Cutler, a board-certified psychiatrist who is also board-qualified in both neurology and clinical pharmacology, has been instrumental in the design and clinical development of nearly 200 compounds in numerous therapeutic areas.
Since creating the first iteration of Worldwide Clinical Trials 30 years ago, he has guided the company with a steadfast commitment to the medicine and science of clinical research.
This, along with his consistent dedication to Worldwide’s customers, were named as key reasons for his receiving the European CEO Award.
Throughout his career, Cutler has been a prominent figure in the industry, having been invited to give hundreds of presentations around the world in the fields of ageing, clinical pharmacology and drug development.
Additionally, he has authored 276 publications, including nine books on the topics of clinical pharmacology, ageing, Alzheimer’s disease, schizophrenia, anxiety disorders and diabetes.
